These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 19155124)

  • 21. [Effect of adenovirus-E1A gene therapy on in vivo radiosensitivity to nasopharyngeal cancer].
    Zhou R; Chen J; Xiao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):744-51. PubMed ID: 19734581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts.
    Shen ZY; Zhang Y; Chen JY; Chen MH; Shen J; Luo WH; Zeng Y
    Oncol Rep; 2004 Jan; 11(1):155-9. PubMed ID: 14654919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice.
    Liu B; Pan S; Dong X; Qiao H; Jiang H; Krissansen GW; Sun X
    Cancer Sci; 2006 Jul; 97(7):675-81. PubMed ID: 16827809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor growth inhibition of metastatic nasopharyngeal carcinoma cell lines by low dose of arsenic trioxide via alteration of cell cycle progression and induction of apoptosis.
    Yeh KY; Chang JW; Li YY; Wang CH; Wang HM
    Head Neck; 2011 May; 33(5):734-42. PubMed ID: 20737493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A patient with progressive multiple myeloma treated successfully with arsenic trioxide after allogeneic bone marrow transplantation.
    Gesundheit B; Shapira MY; Ackerstein A; Resnik IB; Bitan M; Or R
    Acta Haematol; 2007; 117(2):119-21. PubMed ID: 17135719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.
    Ora I; Bondesson L; Jönsson C; Ljungberg J; Pörn-Ares I; Garwicz S; Pâhlman S
    Biochem Biophys Res Commun; 2000 Oct; 277(1):179-85. PubMed ID: 11027660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy.
    Griffin RJ; Williams BW; Park HJ; Song CW
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1516-22. PubMed ID: 15817358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3).
    Li Y; Yu G; Li Q; Wang W; Shen X; Liu H; Liu R
    PLoS One; 2015; 10(4):e0124959. PubMed ID: 25915411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei.
    Moon Y; Park G; Kim Y; Kim M; Lim J; Pai SH; Lee EJ; Kang CS; Han K
    Ann Clin Lab Sci; 2004; 34(3):271-6. PubMed ID: 15487701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W; Adachi M; Zhang R; Zhou J; Zhu D
    Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gefitinib enhances arsenic trioxide (AS2O3)-induced differentiation of acute promyelocytic leukemia cell line.
    Noh EK; Kim H; Park MJ; Baek JH; Park JH; Cha SJ; Won JH; Min YJ
    Leuk Res; 2010 Nov; 34(11):1501-5. PubMed ID: 20226526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo.
    Yu J; Qian H; Li Y; Wang Y; Zhang X; Liang X; Fu M; Lin C
    Gynecol Oncol; 2007 Aug; 106(2):400-6. PubMed ID: 17512576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [hTERT promoter enhances the radiosensitivity to gene-radiation therapy of human laryngeal carcinoma transplanted in nude mice].
    Huang CH; Liao ZK; Zhou FX; Wang WF; Xie CH; Zhang HY; Sun WJ; Zhou YF
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):733-6. PubMed ID: 19173799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
    Ong PS; Chan SY; Ho PC
    Eur J Pharm Sci; 2012 Feb; 45(3):367-78. PubMed ID: 22178533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular targeting therapies for treatment of malignant disease.
    Brown SL; Kolozsvary A; Kim JH
    Cancer; 2005 Jul; 104(1):216-7; author reply 217. PubMed ID: 15895372
    [No Abstract]   [Full Text] [Related]  

  • 39. Vascular disrupting agent arsenic trioxide enhances thermoradiotherapy of solid tumors.
    Griffin RJ; Williams BW; Koonce NA; Bischof JC; Song CW; Asur R; Upreti M
    J Oncol; 2012; 2012():934918. PubMed ID: 22272199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of the inoperable cancer of the bladder with arsenic].
    HEUSCH K
    Z Urol; 1952; 45(Suppl):298-302. PubMed ID: 12995891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.